152 related articles for article (PubMed ID: 9423940)
1. Effects of heparin-coating of cardiopulmonary bypass circuits on leukocytes during simulated extracorporeal circulation.
Borowiec J; Jaramillo A; Venge P; Nilsson L; Thelin S
Cardiovasc Surg; 1997 Dec; 5(6):568-73. PubMed ID: 9423940
[TBL] [Abstract][Full Text] [Related]
2. Biomaterial-dependent blood activation during simulated extracorporeal circulation: a study of heparin-coated and uncoated circuits.
Borowiec JW; Venge P; Henze A; Nilsson B; Stiernström H
Thorac Cardiovasc Surg; 1997 Dec; 45(6):295-301. PubMed ID: 9477462
[TBL] [Abstract][Full Text] [Related]
3. Effects of heparin coating of cardiopulmonary bypass circuits on in vitro oxygen free radical production during coronary bypass surgery.
Bozdayi M; Borowiec J; Nilsson L; Venge P; Thelin S; Hansson HE
Artif Organs; 1996 Sep; 20(9):1008-16. PubMed ID: 8864022
[TBL] [Abstract][Full Text] [Related]
4. Heparin-coated circuits reduce activation of granulocytes during cardiopulmonary bypass. A clinical study.
Borowiec J; Thelin S; Bagge L; Nilsson L; Venge P; Hansson HE
J Thorac Cardiovasc Surg; 1992 Sep; 104(3):642-7. PubMed ID: 1325013
[TBL] [Abstract][Full Text] [Related]
5. Duraflo II coating of cardiopulmonary bypass circuits reduces complement activation, but does not affect the release of granulocyte enzymes : a European multicentre study.
Fosse E; Thelin S; Svennevig JL; Jansen P; Mollnes TE; Hack E; Venge P; Moen O; Brockmeier V; Dregelid E; Haldén E; Hagman L; Videm V; Pedersen T; Mohr B
Eur J Cardiothorac Surg; 1997 Feb; 11(2):320-7. PubMed ID: 9080162
[TBL] [Abstract][Full Text] [Related]
6. Circulating cytokines and granulocyte-derived enzymes during complex heart surgery. A clinical study with special reference to heparin-coating of cardiopulmonary bypass circuits.
Borowiec JW; Hagman L; Tötterman TH; Pekna M; Venge P; Thelin S
Scand J Thorac Cardiovasc Surg; 1995; 29(4):167-74. PubMed ID: 8789469
[TBL] [Abstract][Full Text] [Related]
7. Comparison of three oxygenator-coated and one total-circuit-coated extracorporeal devices.
Baksaas ST; Videm V; Pedersen T; Karlsen H; Mollnes TE; Brosstad F; Svennevig JL
Perfusion; 1999 Mar; 14(2):119-27. PubMed ID: 10338323
[TBL] [Abstract][Full Text] [Related]
8. Heparin-coated circuits reduce complement activation and inflammatory response to cardiopulmonary bypass.
Tamim M; Demircin M; Guvener M; Peker O; Yilmaz M
Panminerva Med; 1999 Sep; 41(3):193-8. PubMed ID: 10568115
[TBL] [Abstract][Full Text] [Related]
9. High and low heparin dose with heparin-coated cardiopulmonary bypass: activation of complement and granulocytes.
Ovrum E; Mollnes TE; Fosse E; Holen EA; Tangen G; Ringdal MA; Videm V
Ann Thorac Surg; 1995 Dec; 60(6):1755-61. PubMed ID: 8787476
[TBL] [Abstract][Full Text] [Related]
10. Complement and granulocyte activation in two different types of heparinized extracorporeal circuits.
Ovrum E; Mollnes TE; Fosse E; Holen EA; Tangen G; Abdelnoor M; Ringdal MA; Oystese R; Venge P
J Thorac Cardiovasc Surg; 1995 Dec; 110(6):1623-32. PubMed ID: 8523872
[TBL] [Abstract][Full Text] [Related]
11. Endothelin-1 and neutrophil activation during heparin-coated cardiopulmonary bypass.
Lundblad R; Moen O; Fosse E
Ann Thorac Surg; 1997 May; 63(5):1361-7. PubMed ID: 9146328
[TBL] [Abstract][Full Text] [Related]
12. Heparin-coated circuits reduce the formation of TNF alpha during cardiopulmonary bypass.
Yamada H; Kudoh I; Hirose Y; Toyoshima M; Abe H; Kurahashi K
Acta Anaesthesiol Scand; 1996 Mar; 40(3):311-7. PubMed ID: 8721461
[TBL] [Abstract][Full Text] [Related]
13. In vitro evaluation of new surface coatings for extracorporeal circulation.
Baksaas ST; Videm V; Fosse E; Karlsen H; Pedersen T; Mollnes TE; Hagve TA; Svennevig JL
Perfusion; 1999 Jan; 14(1):11-9. PubMed ID: 10074642
[TBL] [Abstract][Full Text] [Related]
14. Complete heparin-coated cardiopulmonary bypass and low heparin dose reduce complement and granulocyte activation.
Ovrum E; Fosse E; Mollnes TE; Am Holen E; Tangen G; Abdelnoor M; Ringdal MA; Oystese R; Venge P
Eur J Cardiothorac Surg; 1996; 10(1):54-60. PubMed ID: 8776186
[TBL] [Abstract][Full Text] [Related]
15. Biocompatibility of heparin-coated extracorporeal bypass circuits: a randomized, masked clinical trial.
Muehrcke DD; McCarthy PM; Kottke-Marchant K; Harasaki H; Pierre-Yared J; Borsh JA; Ogella DA; Cosgrove DM
J Thorac Cardiovasc Surg; 1996 Aug; 112(2):472-83. PubMed ID: 8751516
[TBL] [Abstract][Full Text] [Related]
16. Veno-venous bypass in liver transplantation: heparin-coated perfusion circuits reduce the activation of humoral defense systems in an in vitro model.
Scholz T; Solberg R; Okkenhaug C; Videm V; Gallimore MJ; Mathisen O; Pedersen T; Mollnes TE; Bergan A; Søreide O; Klintmalm GB; Aasen AO
Perfusion; 2001 Jul; 16(4):285-92. PubMed ID: 11486847
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory response during simulated extracorporeal circulation with addition of nitric oxide.
Borowiec JW; Lahtinen M; Venge P; Henze A; Stiernström H
J Cardiovasc Surg (Torino); 2000 Apr; 41(2):207-13. PubMed ID: 10901523
[TBL] [Abstract][Full Text] [Related]
18. Reduced granulocyte activation with a heparin-coated device in an in vitro model of cardiopulmonary bypass.
Videm V; Nilsson L; Venge P; Svennevig JL
Artif Organs; 1991 Apr; 15(2):90-5. PubMed ID: 1852153
[TBL] [Abstract][Full Text] [Related]
19. Heparin coating of the extracorporeal circuit combined with leukocyte filtration reduces coagulation activity, blood loss and blood product substitution.
Martens S; Matheis G; Wimmer-Greinecker G; Feuerbach J; Jakob A; Mierdl S; Moritz A
Int J Artif Organs; 2001 Jul; 24(7):484-8. PubMed ID: 11510921
[TBL] [Abstract][Full Text] [Related]
20. Effects of heparin coating on the expression of CD11b, CD11c and CD62L by leucocytes in extracorporeal circulation in vitro.
Høgevold HE; Moen O; Fosse E; Venge P; Bråten J; Andersson C; Lyberg T
Perfusion; 1997 Mar; 12(1):9-20. PubMed ID: 9131716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
